Mikael Mortensen

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden.

AB Inventech A/S provides automation solutions for surface treatment processes such as sand blasting, grit blasting, metallizing, paint robot, and dry lube application. The company is based in Ikast, Denmark. The Danish company also has expertise in handling composite materials like prepreg, dry glass fiber, carbon fiber, and carbon pultrusion. The company was founded in 1989 by Arne Just Beck, and the CEO is Niels Kirkegaard. AB Inventech was acquired by Alder AB on December 17, 2021.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.

JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York.

Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA.

Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden.

Nordic Water Products AB operates as a holding company with interest in providing equipment and systems for water and wastewater treatment to process industries and public utilities. Its products include continuous sand filters, sludge scrapers, surface skimmers, flocculators, sludge discharge equipment, fine screens, wash presses, screenings treatment, grit treatment, sludge treatment, lamella separators, and conveyor systems. The company was founded in 1962 and is headquartered in Vastra Frolunda, Sweden.

American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA.

Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA.

AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021.

Coeli Private Equity Management AB (CPEM) is a Swedish private equity investment firm with offices in Stockholm, Uppsala, and Gothenburg. They are a subsidiary of the Swedish financial firm Coeli AB. CPEM is the investment manager of the Coeli Private Equity funds. They cater to private individuals and smaller investors. Part of the firm's mission is to create indirect access for private investors to invest in private equity fund of funds through their own shareholdings in private equity funds.

Sjätte AP-fonden (AP6) is a private equity division of Sjätte AP-fonden founded in 1996. the firm is headquartered in Gothenburg, Stockholm.

Sjätte AP-fonden (AP6) is an asset management firm controlled by the Government of Sweden. Also known as The Sixth AP Fund, the firm was founded in 1996 and is headquartered in Göteborg, Sweden. AP6 manages a buffer fund for the earnings-related pension scheme of the Swedish pension system and provides pension fund management services for Swedish corporate clients and their employees. They are a socially responsible investor which is affiliated with and complies with the UN Global Compact and Principles for Responsible Investment.

Avantus Corporate Finance KB provides finance advisory services for mergers & acquisitions and fundraisings. Its services include selling companies, acquiring companies, private placement and road to exit och value by growth. The company was founded by Dag Sigurd Anders Ingle in 1999 and is headquartered in Stockholm, Sweden.

Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.

Jernforsen Energi System AB develops and manufactures bio fuel heating plants. It offers district heating, cogeneration, and drying plants. The firm also engages in the development and production of biomass combustion plants. The company was founded in 1984 and is headquartered in Järnforsen, Sweden.

r2p GmbH operates as a holding company, which engages in the provision of public transport and mobility solutions. The firm offers mobile CCTV, automatic passenger counting, passenger information systems, passenger wifi, network audio solutions, as well as telematics and tracking. It also focuses on fleet management with real-time data transfer for rail and road vehicles, as well as platforms and stations. The company was founded by Ulrik Ortiz Rasmussen in 2009 and is headquartered in Flensburg, Germany.

Renz Sweden AB manufactures and distributes budget compact boxes. The private company is based in Jönköping, Sweden.

A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden.

Masimo Sweden AB develops and markets ultra-small gas monitoring probes. It sells mobile multigas analyzers that enable to measure respiratory gases in any clinical application. The firms products include IRMA Mainstream Analyzers, ISA Sidestream Analyzers, Nomoline Sampling Lines, EMMA Capnometers, and EMMA Carnograph. The company was founded by Anders Eckerbom and Robert Zyzanski in 1989 and is headquartered in Danderyd, Sweden.

Coala-Life AB develops a medical device that connects the person's heart to the cloud, for remote screening and monitoring of heart and lungs. The company was founded by Philip Axel Wilhelm Siberg, Magnus Samuelsson and Ulf Roger Tossman on April 15, 2004 and is headquartered in Stockholm, Sweden.

Paradinero AB provides security brokerage and management consulting services.

Alder AB is an Independent Private Equity/Venture Capital firm founded in 2010 by Dag Lagesson Broman. Alder AB is headquartered in Stockholm.

Combiplate Sweden AB sells electronic components. The private company is based in Sweden.

Part of NTG Nordic Transport Group A/S, A. Carlsson Research AB develops and discovers new pharmacological treatment principles for psychiatric and neurological disorders. The company is based in Gothenburg, Sweden. The CEO of the Swedish company is Arvid M. Carlsson. A. Carlsson Research was acquired by NTG Nordic Transport Group A/S on October 23, 2006 for $121.91 million.